The pharmaceutical community is abuzz about Retatrutide 120 , a twin-action therapy showing remarkable results in clinical studies . This innovative compound, a GLP-1 receptor agonist alongside a similar compound, appears to effectively decrease body mass and enhance metabolic markers. Experts ar